1-4 of 4
Maria Heinßmann
Close
Sort by
Journal Articles

The GSK3β-Phosphorylation Sites in the DEK-Portion Are Indispensable for the Leukemogenic Potential of the DEK/CAN Fusion Protein in t(6;9)-Positive Acute Myeloid Leukemia

Claudia Oancea, PhD, Maria Heinßmann, Nathalie Guillen, Oliver G. Ottmann, MD, Martin Ruthardt, MD
Journal: Blood
Blood (2014) 124 (21): 3574.
https://doi.org/10.1182/blood.V124.21.3574.3574
Published: 2014
Journal Articles

T(6;9)-DEK/CAN-Positive Leukemia: Role of FLT3-ITD for the Determination of the Leukemic Phenotype

Maria Heinssmann, Lena Drangmeister, Katharina Schmid, Maren Keller, Hubert Serve, Prof. Dr. med., Claudia Oancea, Martin Ruthardt, MD, Gesine Bug
Journal: Blood
Blood (2012) 120 (21): 1316.
https://doi.org/10.1182/blood.V120.21.1316.1316
Published: 2012
Journal Articles

Enzymatically Inactive 5-Lipoxygenase Inhibits Wnt-Signaling Activation Induced by Leukemia Inducing Oncogenes.

Jessica Roos, Maria Heinßmann, Claudia Oancea, Thorsten Maier, Dieter Steinhilber, Hubert Serve, MD, Martin Ruthardt, MD
Journal: Blood
Blood (2012) 120 (21): 2424.
https://doi.org/10.1182/blood.V120.21.2424.2424
Published: 2012
Journal Articles

The Activation of STAT3 and 5 in t(6;9)(DEK/CAN)-Positive Acute Myeloid Leukemia Models Is Inhibited by Exposure to Arsenic Trioxide

Claudia Oancea, Hannelore Held, Maria Heinssmann, Boris Brill, Hubert Serve, Prof. Dr. med., Martin Ruthardt, MD
Journal: Blood
Blood (2012) 120 (21): 1384.
https://doi.org/10.1182/blood.V120.21.1384.1384
Published: 2012